AI assistant
CONMED Corp — Director's Dealing 2023
Mar 3, 2023
31971_dirs_2023-03-03_c327e51a-652c-411b-8a37-d313bc6f1388.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-03-01
Reporting Person: Jonas Daniel S (Special Counsel & Corp Secy)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-03-01 | Common Stock | M | 2500 | — | Acquired | 14784 | Direct |
| 2023-03-01 | Common Stock | F | 736 | $96.16 | Disposed | 14048 | Direct |
| 2023-03-02 | Common Stock | M | 5400 | $59.96 | Acquired | 19448 | Direct |
| 2023-03-02 | Common Stock | S | 5400 | $96.245 | Disposed | 14048 | Direct |
| 2023-03-02 | Common Stock | M | 5000 | $78.76 | Acquired | 19048 | Direct |
| 2023-03-02 | Common Stock | S | 5000 | $96.0762 | Disposed | 14048 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-03-01 | Rsus (restricted Stock Units) | $0 | M | 2500 | Disposed | 2032-03-01 | Common Stock (2500) | Direct |
| 2023-03-01 | Rsus (restricted Stock Units) | $0 | A | 3000 | Acquired | 2033-03-01 | Common Stock (3000) | Direct |
| 2023-03-02 | Options To Purchase Common Stock | $59.96 | M | 5400 | Disposed | 2028-03-01 | Common Stock (5400) | Direct |
| 2023-03-02 | Options To Purchase Common Stock | $78.76 | M | 5000 | Disposed | 2029-03-01 | Common Stock (5000) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.03 to $96.24. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting 100% after a one year period.
F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting in equal amounts (1000 units) over a three year period.
F4: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
F5: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period